Development of cardiac hypertrophy and its relationship to the cardiac baroreflex deficit in hypertension.
Head
G A
GA
Baker Medical Research Institute, Prahran, Victoria, Australia.
Minami
N
N
Adams
M A
MA
Bobik
A
A
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001262:Atenolol / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D006332:Cardiomegaly / Q000209:etiology / Q000503:physiopathology*; D006339:Heart Rate / Q000187:drug effects; D006973:Hypertension / Q000150:complications / Q000503:physiopathology*; D007211:Indoles / Q000494:pharmacology; D020913:Perindopril; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D012018:Reflex / Q000187:drug effects; D014630:Vagus Nerve / Q000502:physiology
D000959:Antihypertensive Agents; D007211:Indoles; D001262:Atenolol; D001285:Atropine; D020913:Perindopril